Genomic variant interpretation platform for clinical labs and researchers
Saphetor operates a bioinformatics platform centered on VarSome, a variant database and classification engine powered by 150+ integrated genomic data sources and AI-linked to 32 million publications. The tech stack is infrastructure-heavy (Terraform, Ansible, GCP, OCI, GitHub Actions, gRPC) with embedded C++ for high-performance genetic data processing—reflecting the computational demands of clinical-grade sequencing analysis. Active projects span CI/CD automation, observability (logging/monitoring/alerting), and oncology-specific product work, signaling a move toward enterprise deployment and specialized disease domains.
Saphetor is a precision-medicine company based in Lausanne, Switzerland, founded in 2014. The company builds VarSome, a suite of bioinformatics tools for variant interpretation, serving three segments: individual researchers needing search and analysis tools, professional clinical labs requiring CE-IVD and HIPAA-compliant platforms, and bioinformaticians integrating via API. The platform classifies germline and somatic variants against ACMG and AMP standards using proprietary algorithms. VarSome's database is enriched by a global user community exceeding 600,000 members. With 51–200 employees, Saphetor operates across engineering, product, sales, marketing, and ops, with current hiring acceleration in Greece, Bulgaria, and Egypt.
Saphetor uses Python, C++, GCP, OCI, Terraform, Ansible, GitHub Actions, gRPC, Redis, and Linux. Testing and QA rely on Selenium, Pytest, Postman, TestRail, and SoapUI.
Active projects include automation and testing framework development, cloud/on-premises infrastructure as code, CI/CD pipelines, observability systems, C++ core applications for genetic data analysis, clinical annotation tools, platform scalability, and oncology product initiatives.
Other companies in the same industry, closest in size